Pitcairn CO Medpace Holdings, Inc. Transaction History

Pitcairn CO

$1.24 Billion
Q3 2025

A detailed history of Pitcairn CO transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Pitcairn CO holds 850 shares of MEDP stock, worth $501,576. This represents 0.04% of its overall portfolio holdings.

Number of Shares

850

Previous 2,132 60.13%

Holding current value

$501,576

Previous $669,000 34.68%

% of portfolio

0.04%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$308.88 - $514.16 $395,984 - $659,153	-1,282 Reduced 60.13%	850 $437,000
Q2 2025 Aug 18, 2025	SELL	$277.23 - $315.28 $4.64 Million - $5.27 Million	-16,721 Reduced 88.69%	2,132 $669,000
Q2 2025 Aug 14, 2025	BUY	$277.23 - $315.28 $4.57 Million - $5.19 Million	16,469 Added 690.81%	18,853 $5.92 Million
Q1 2025 May 09, 2025	SELL	$304.69 - $360.97 $2,742 - $3,248	-9 Reduced 0.38%	2,384 $726,000
Q4 2024 Feb 12, 2025	SELL	$308.93 - $363.58 $13,283 - $15,633	-43 Reduced 1.77%	2,393 $795,000

Q3 2024 Nov 12, 2024	SELL	$320.58 - $457.29 $109,638 - $156,393	-342 Reduced 12.31%	2,436 $812,000
Q2 2024 Aug 13, 2024	BUY	$372.0 - $424.34 $24,924 - $28,430	67 Added 2.47%	2,778 $1.14 Million
Q1 2024 May 13, 2024	SELL	$284.87 - $413.31 $66,374 - $96,301	-233 Reduced 7.91%	2,711 $1.1 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $20,704 - $28,453	-91 Reduced 3.0%	2,944 $902,000
Q3 2023 Nov 13, 2023	SELL	$233.98 - $281.67 $108,098 - $130,131	-462 Reduced 13.21%	3,035 $734,000
Q2 2023 Aug 11, 2023	SELL	$187.26 - $240.17 $17,789 - $22,816	-95 Reduced 2.64%	3,497 $839,000
Q1 2023 May 05, 2023	SELL	$174.31 - $239.52 $102,842 - $141,316	-590 Reduced 14.11%	3,592 $675,000
Q4 2022 Feb 13, 2023	SELL	$153.06 - $226.57 $36,428 - $53,923	-238 Reduced 5.38%	4,182 $888,000
Q3 2022 Nov 10, 2022	BUY	$145.13 - $182.49 $9,433 - $11,861	65 Added 1.49%	4,420 $695,000
Q2 2022 Aug 12, 2022	BUY	$130.2 - $168.03 $32,549 - $42,007	250 Added 6.09%	4,355 $652,000
Q1 2022 May 12, 2022	SELL	$138.87 - $214.31 $12,359 - $19,073	-89 Reduced 2.12%	4,105 $672,000
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $251,632 - $313,818	-1,377 Reduced 24.72%	4,194 $913,000
Q3 2021 Nov 10, 2021	SELL	$170.18 - $198.21 $4,084 - $4,757	-24 Reduced 0.43%	5,571 $1.06 Million
Q2 2021 Aug 11, 2021	SELL	$158.62 - $194.3 $32,517 - $39,831	-205 Reduced 3.53%	5,595 $988,000
Q1 2021 May 10, 2021	SELL	$132.02 - $168.26 $212,948 - $271,403	-1,613 Reduced 21.76%	5,800 $951,000
Q4 2020 Feb 05, 2021	SELL	$109.38 - $149.19 $2,515 - $3,431	-23 Reduced 0.31%	7,413 $1.03 Million
Q3 2020 Nov 03, 2020	BUY	$92.95 - $130.61 $25,375 - $35,656	273 Added 3.81%	7,436 $831,000
Q2 2020 Jul 28, 2020	SELL	$68.08 - $95.68 $37,784 - $53,102	-555 Reduced 7.19%	7,163 $666,000
Q1 2020 May 13, 2020	BUY	$61.71 - $101.95 $240,298 - $396,993	3,894 Added 101.83%	7,718 $566,000
Q4 2019 Feb 12, 2020	BUY	$70.08 - $84.64 $70,360 - $84,978	1,004 Added 35.6%	3,824 $321,000
Q3 2019 Nov 12, 2019	BUY	$62.38 - $85.89 $175,911 - $242,209	2,820 New	2,820 $237,000

Others Institutions Holding MEDP

# of Institutions

732

Shares Held

24.8M

Call Options Held

104K

Put Options Held

187K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $18.4B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account